S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

XERS Xeris Biopharma Holdings Inc

1.775

-0.01 (-0.56%)

Last Updated: 04:01:20

Delayed by 15 minutes

Annual Report to Security Holders (ars)

This regulatory filing also includes additional resources:
a2022form10-kforprinterxars.pdf

Xeris Biopharma (NASDAQ:XERS)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Xeris Biopharma Charts.

Xeris Biopharma (NASDAQ:XERS)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Xeris Biopharma Charts.

Xeris Biopharma Holdings, Inc. News

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Thursday 4 April 2024 (3 weeks ago) • Business Wire

Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Tuesday 2 April 2024 (3 weeks ago) • Business Wire

Form S-8 - Securities to be offered to employees in employee benefit plans
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events
Wednesday 6 March 2024 (2 months ago) • Business Wire

Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital
Wednesday 6 March 2024 (2 months ago) • Business Wire

Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024
Wednesday 28 February 2024 (2 months ago) • Business Wire

Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference
Monday 5 February 2024 (3 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 1 February 2024 (3 months ago) • Edgar (US Regulatory)

Xeris Biopharma Shares Climb 12% on Amgen License Agreement
Thursday 11 January 2024 (3 months ago) • Dow Jones News

Xeris Biopharma Reaches License Agreement With Amgen On Thyroid Eye Disease Treatment
Thursday 11 January 2024 (3 months ago) • Dow Jones News

More Xeris Biopharma Holdings, Inc. News Articles

AUD vs US Dollar

Australia And New Zealan...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions